Orchard Therapeutics PLC (NASDAQ:ORTX)

Delayed Data
As of Oct 17
 +1.05 / +9.11%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Orchard Therapeutics PLC have a median target of 27.00, with a high estimate of 31.00 and a low estimate of 21.00. The median estimate represents a +114.63% increase from the last price of 12.58.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Orchard Therapeutics PLC. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 27

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 25.89%
Growthannually 82.97%


Growthquarterly --
Growthannually -60.92%
Key to the earnings and sales forecast charts.